Halozyme Announces Janssen Submits New Drug Application In Japan For Daratumumab Subcutaneous Formulation Utilizing Halozyme's ENHANZE® Technology For Patients With Multiple Myeloma
$HALO $JNJ #mmsm #myeloma 
https://t.co/Nij3lQXK2d